Martin Marietta Materials heads into its July 30 earnings report with analyst sentiment quietly firming, even as the stock trades well below where most of the Street has it priced.
The most immediate story is on the analyst desk. Both Citigroup and Wells Fargo raised their price targets on MLM this morning — Citigroup lifting to $737 from $731, Wells Fargo moving to $616 from $614. Neither changed their rating. That double move on the same day, small in size but concurrent in timing, signals the Street is gently marking up assumptions ahead of the Q2 print. The consensus mean target is $682, roughly 15% above the current price of $594.17. Truist lifted its target to $730 earlier in May after Q1 results, while Morgan Stanley and RBC both trimmed targets in April. The net direction since late April has been upward revision, with bulls holding Buy targets in the $730s and the more cautious voices — Wells Fargo's Equal-Weight at $616, RBC's Sector Perform at $615 — clustered just above where the stock is now.
The bull case rests on aggregates volume and pricing momentum. The company posted 17% year-over-year aggregates revenue growth in its most recent quarter, with both volume and pricing up 8%, and raised its full-year guidance. Bears counter that the "value over volume" strategy could create friction in markets where MLM's pricing runs below its corporate average — particularly where competes — and that geographic concentration in Texas, North Carolina, Colorado, California, and Georgia leaves the company exposed to regional demand swings. The EPS surprise factor score ranks in the 99th percentile, meaning the company has a strong track record of beating estimates. The forward EPS momentum score over 12 months is weak at 5, though the 30-day reading is healthier at 59, suggesting near-term revisions are more constructive. Valuation is not cheap: PE is running near 29x and EV/EBITDA around 16.9x, both up on the month as the stock has recovered.
Positioning in the lending market tells a quiet story. Short interest has been building steadily — up roughly 5.5% over the past week and 35% from its early-June trough — to reach 4.0% of the free float. That is worth noting, but it is not extreme territory. More telling is the availability picture: with roughly 1,173% availability, there are far more shares available to borrow than currently borrowed, meaning the lending market is loose and there is no meaningful squeeze pressure. Borrow costs have edged higher, now at 0.51%, up about 17% over the past month, but remain low in absolute terms. The ORTEX short score of 40.8 places MLM in the bottom third of the short-score universe — a reading that reflects moderate but not alarming short-side interest. Options confirm the lack of anxiety: the put/call ratio at 0.39 is below its 20-day average of 0.47, near its 52-week low of 0.32, and running just over half a standard deviation below the mean. Call activity is outpacing puts, a moderately constructive tilt heading into the print.
Among close peers, the week told a more fragmented story. VMC fell 1.3% on the week while CRH dropped 2.4%. EXP was hit harder, down 6.4%. MLM's 3% weekly gain — despite a 1.8% pullback on Tuesday — left it as the relative outperformer against its US aggregates peers. That divergence may partly reflect the constructive analyst flow this week, though the stock still closed at $594, well beneath the levels where most of the covering analysts have set their targets.
With Q2 results due July 30, the key question heading into the print is whether aggregates pricing held its momentum and whether the company's volume guidance proves conservative again — rather than whether the fundamental thesis holds.
See the live data behind this article on ORTEX.
Open MLM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
